China SFDA Orders Vital Pharma To Recall Hemorrhoid Drug
This article was originally published in PharmAsia News
Executive Summary
China's State FDA has ordered a recall of the Zhixue (depile) hemorrhoid drug made by Vital Pharmaceutical Holdings. The agency said 21 patients developed liver problems over the past several months after taking the capsules. In addition, another 14 people have been reported with adverse effects. The SFDA also ordered Vital to stop producing the capsules as it conducts a national recall. A statement from the agency said there is an obvious connection between the damage and the capsules, but it had not determined the cause. (Click here for more